Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
Provided By GlobeNewswire
Last update: May 8, 2025
SAN MATEO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported financial results for the quarter ended March 31, 2025, and provided recent corporate updates.
Read more at globenewswire.comNASDAQ:SGMT (6/17/2025, 3:20:41 PM)
6.92
-0.48 (-6.49%)
Find more stocks in the Stock Screener
SGMT Latest News and Analysis
5 days ago - ChartmillHere are the top movers in Thursday's session.Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
13 days ago - ChartmillThese stocks are moving in today's pre-market sessionAs we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
